These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 7981338)

  • 1. Spurious Hyperphosphatemia in Two Children With End-Stage Renal Disease: A Case Report.
    Ahmed FS; Begum M; AlSharhan MA
    Cureus; 2024 Mar; 16(3):e55818. PubMed ID: 38590456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphate control in dialysis.
    Cupisti A; Gallieni M; Rizzo MA; Caria S; Meola M; Bolasco P
    Int J Nephrol Renovasc Dis; 2013 Oct; 6():193-205. PubMed ID: 24133374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spurious hyperphosphatemia in patients on hemodialysis with catheters.
    Schiller B; Virk B; Blair M; Wong A; Moran J
    Am J Kidney Dis; 2008 Sep; 52(3):617-20. PubMed ID: 18534730
    [No Abstract]   [Full Text] [Related]  

  • 4. Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheter.
    Cachat F; Bardy D; Durussel C; Di Paolo E
    Pediatr Nephrol; 2006 Feb; 21(2):301-2. PubMed ID: 16328539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spurious hyperphosphatemia in patients with dysglobulinemia.
    Weinberg J; Adler AJ
    Miner Electrolyte Metab; 1989; 15(4):185-6. PubMed ID: 2761487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spuriously high phosphate level which is promptly resolved after plasmapheresis in a patient with multiple myeloma.
    Kiki I; Gundogdu M; Kaya H
    Transfus Apher Sci; 2007 Oct; 37(2):157-9. PubMed ID: 18037346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudohyperphosphatemia in a patient with multiple myeloma.
    Marcu CB; Hotchkiss M
    Conn Med; 2004 Feb; 68(2):71-2. PubMed ID: 15007869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spurious hyperphosphatemia in multiple myeloma].
    Jarchovsky I; Beitner H; Plavnick L
    Harefuah; 1991 Dec; 121(12):515-6. PubMed ID: 1794758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited.
    Sinclair D; Smith H; Woodhead P
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):119-24. PubMed ID: 15025801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudohyperphosphataemia incidence in an automatic analyzer.
    Cohen AM; Magazanik A; van-der Lijn E; Shaked P; Levinsky H
    Eur J Clin Chem Clin Biochem; 1994 Jul; 32(7):559-61. PubMed ID: 7981338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferences in the measurement of circulating phosphate: a literature review.
    Molinaris V; Bianchetti MG; Milani GP; Lava SAG; Bruna RD; Simonetti GD; Faré PB
    Clin Chem Lab Med; 2020 Nov; 58(12):1971-1977. PubMed ID: 32549132
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.